Skip to main content
Journal cover image

Modulation of immune system inhibitory checkpoints in colorectal cancer

Publication ,  Journal Article
Patel, SP; Osada, T; Osada, K; Hurwitz, H; Lyerly, HK; Morse, MA
Published in: Current Colorectal Cancer Reports
December 1, 2013

T cell infiltration of colorectal cancer is associated with improved clinical outcome, underlining the importance of the immune system in cancer control; however, immune checkpoints, including the inhibitory T cell molecules CTLA-4 and PD-1 that temper the native immune response, mitigating autoimmunity, are coopted by tumors to facilitate escape from immune surveillance. Blockade of CTLA-4 and PD-1 and its ligand PD-L1, expressed by many tumors, have shown impressive activity in melanoma, renal cell carcinoma, and lung cancer. Immune checkpoint inhibition has been less well studied in colorectal cancer, but preclinical and clinical investigations are in progress. © Springer Science+Business Media New York 2013.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Current Colorectal Cancer Reports

DOI

EISSN

1556-3804

ISSN

1556-3790

Publication Date

December 1, 2013

Volume

9

Issue

4

Start / End Page

391 / 397
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Patel, S. P., Osada, T., Osada, K., Hurwitz, H., Lyerly, H. K., & Morse, M. A. (2013). Modulation of immune system inhibitory checkpoints in colorectal cancer. Current Colorectal Cancer Reports, 9(4), 391–397. https://doi.org/10.1007/s11888-013-0184-3
Patel, S. P., T. Osada, K. Osada, H. Hurwitz, H. K. Lyerly, and M. A. Morse. “Modulation of immune system inhibitory checkpoints in colorectal cancer.” Current Colorectal Cancer Reports 9, no. 4 (December 1, 2013): 391–97. https://doi.org/10.1007/s11888-013-0184-3.
Patel SP, Osada T, Osada K, Hurwitz H, Lyerly HK, Morse MA. Modulation of immune system inhibitory checkpoints in colorectal cancer. Current Colorectal Cancer Reports. 2013 Dec 1;9(4):391–7.
Patel, S. P., et al. “Modulation of immune system inhibitory checkpoints in colorectal cancer.” Current Colorectal Cancer Reports, vol. 9, no. 4, Dec. 2013, pp. 391–97. Scopus, doi:10.1007/s11888-013-0184-3.
Patel SP, Osada T, Osada K, Hurwitz H, Lyerly HK, Morse MA. Modulation of immune system inhibitory checkpoints in colorectal cancer. Current Colorectal Cancer Reports. 2013 Dec 1;9(4):391–397.
Journal cover image

Published In

Current Colorectal Cancer Reports

DOI

EISSN

1556-3804

ISSN

1556-3790

Publication Date

December 1, 2013

Volume

9

Issue

4

Start / End Page

391 / 397